IP Verse

Am competitive analysis

Latest oppositions filed by Am

Explore patent oppositions filed by Am against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Feb 19, 2026
Patent NumberTitleApplicantOpposition Date
EP3553174
Rna-Guided Human Genome EngineeringPRESIDENT AND FELLOWS OF HARVARD COLLEGEJan 30, 2026
EP3592732
Manufacture Of A Crystalline Pharmaceutical ProductORIONJan 8, 2026
EP3867372
Methods For Targeted Insertion Of Dna In GenesBLUEALLELEJan 2, 2026
EP3923890
Absorbent ArticleESSITY HYGIENE AND HEALTH AKTIEBOLAGJan 2, 2026
EP4039425
Blade Set For A Hair ClipperWAHLJan 2, 2026
EP3756650
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEDec 19, 2025
EP3798224
Solid State Forms Of Ixazomib CitrateASSIA CHEMICAL INDUSTRIESDec 19, 2025
EP3973764
Agricultural Machine With Nir Sensor And Data Processing SystemCLAAS SELBSTFAHRENDE ERNTEMASCHINENDec 19, 2025
EP4267105
Antibody Compositions And Methods Of Use ThereofBRISTOL MYERS SQUIBBDec 19, 2025
EP4312925
Absorbent CompositesBERRYDec 19, 2025

Latest patents of Am opposed by its competitors

Explore Am's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Feb 19, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3028842
Oct 8, 2025Powder Compositions Made Of Thermoplastics And Use Of The Compositions4
EP3381942
Oct 1, 2025A Method For Treating Melanoma Using A Herpes Simplex Virus And An Immune Checkpoint Inhibitor1
EP3658203
Oct 1, 2025Drug Delivery Device With Gear Module And Related Method Of Assembly2
EP3756650
Aug 20, 2025Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione5
EP3369420
Mar 12, 2025Compositions And Methods For Improving Mitochondrial Function And Treating Neurodegenerative Diseases And Cognitive Disorders2
EP3372228
Mar 12, 2025Compositions And Methods For Improving Mitochondrial Function And Treating Neurodegenerative Diseases And Cognitive Disorders1
EP3706606
Feb 5, 2025Ovenable Package1
EP3930478
Jan 29, 2025Stable Protein Formulations2
EP4161241
Dec 18, 2024Agricultural Attachment For Cultivating Row Crops1
EP4114390
Dec 4, 2024Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla Gene2

Latest PTAB cases involving Am

Discover the latest PTAB cases involving Am, highlighting their recent legal challenges and patent disputes.

Last updated on: Feb 23, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Am

IPR2026-00193Jan 9, 2026AMAZONCOMINTERDIGITAL VCPending
IPR2026-00195Jan 9, 2026AMAZONCOMINTERDIGITAL MADISONPending
IPR2026-00192Jan 5, 2026AMAZONCOM SERVICESINTERDIGITAL VCPending
IPR2026-00148Nov 22, 2025AMAZONCOM SERVICESSMART SPEAKERPending
IPR2026-00145Nov 21, 2025AMAZONCOM SERVICESSMART SPEAKERPending
IPR2026-00146Nov 21, 2025AMAZONCOM SERVICESSMART SPEAKERPending
IPR2026-00147Nov 21, 2025AMAZONCOM SERVICESSMART SPEAKERPending
IPR2026-00088Nov 10, 2025AMAZONCOM SERVICESHEADWATER RESEARCHPending
IPR2026-00106Nov 10, 2025AMAZONCOM SERVICESHEADWATER RESEARCHPending
IPR2026-00043Oct 10, 2025AMERICAN AIRLINESINTELLECTUAL VENTURES IIDiscretionary Denial

Peer Comparison New

IP litigation analysis comparing Am with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Feb 19, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AMGEN8138811
JAMES POOLE156 - - -
REGENERON PHARMACEUTICALS3894931
STRAWMAN349 - - -